Market Capitalization (Millions $) |
74 |
Shares
Outstanding (Millions) |
14 |
Employees |
- |
Revenues (TTM) (Millions $) |
49 |
Net Income (TTM) (Millions $) |
-10 |
Cash Flow (TTM) (Millions $) |
-7 |
Capital Exp. (TTM) (Millions $) |
2 |
Champions Oncology Inc
Champions Oncology Inc is a biotechnology company that specializes in developing and providing personalized medicine solutions for cancer patients. The company offers services that include creating patient-derived tumor xenograft (PDX) models, which are used for drug testing and development. These PDX models are derived directly from patients' tumors and aim to replicate the complexity and diversity of the original tumor biology, allowing for more accurate and personalized treatment approaches. Champions Oncology's services also include biomarker analysis, genetic profiling, and drug sensitivity testing. The company collaborates with pharmaceutical and biotechnology companies to advance the development of new cancer therapies.
Company Address: One University Plaza, Suite 307 Hackensack 7601 NJ
Company Phone Number: 808-8400 Stock Exchange / Ticker: NASDAQ CSBR
|